{"schema_version":"secwatch.filing_event.v1","accession":"0001599298-24-000025","form_type":"8-K","ticker":"SMMT","cik":"0001599298","company_name":"Summit Therapeutics Inc.","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.759060+00:00","generated_at":"2026-06-06T01:14:55.630531+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Summit Therapeutics presents at Oppenheimer conference; no material new information in filing","bullets":["Presented at Oppenheimer's 34th Annual Healthcare Life Sciences Conference on February 14, 2024.","CEO Dr. Maky Zanganeh and Chairman Bob Duggan listed as presenters.","No financial data, clinical updates, or material business developments disclosed in the available exhibit.","Presentation slides furnished under Regulation FD but not filed with the SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001599298-24-000025","json":"https://secwatch.observer/filing/0001599298-24-000025.json","markdown":"https://secwatch.observer/filing/0001599298-24-000025.md","text":"https://secwatch.observer/filing/0001599298-24-000025.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000025/0001599298-24-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000025/smmt-20240214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T01:14:55.630531+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}